Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
253
datasets available to search
ShareScore release 0.9.0
Dataset results
253 results for “gefitinib;”
A Safety and Efficacy Study of INC280 and Gefitinib in Patients With EGFR Mutated, c-MET-amplified NSCLC Who Have Progressed After EGFRi Treatment
ClinicalTrials.gov study NCT01610336. IPD Sharing: YES. Countries: 14. Publications: 1.
DS-1205c With Gefitinib for Metastatic or Unresectable Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT03599518. IPD Sharing: YES. Countries: 1. Publications: 1.
Uncovering the molecular basis for the better Gefitinib sensitivity of EGFR with complex mutations over single rare mutation: insights from molecular simulations
<p>Molecular Dynamics trajectories and topology files of APO and Gefitinib(IRE)-bound Epidermal growth factor receptor (EGFR) mutants: rare (G719S), rare + rare (G719S/L861Q) and rare + classical (G719S/L858R). The trajectories presented in this work were analyzed and presented in "Uncovering the molecular basis for the better Gefitinib sensitivity of EGFR with complex mutations over single rare mutation: insights from molecular simulations".</p>
LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung
ClinicalTrials.gov study NCT01466660. IPD Sharing: Not stated. Countries: 14. Publications: 3.
LUX-Lung 4: BIBW 2992 (Afatinib) Phase I Trial in Advanced Non Small Cell Lung Cancer Patients & Phase II Trial in Non Small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib
ClinicalTrials.gov study NCT00711594. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Gefitinib, Trastuzumab, and Docetaxel in Treating Patients With Metastatic Breast Cancer
ClinicalTrials.gov study NCT00086957. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Assess the Efficacy, Safety and Tolerability of Gefitinib (Iressa® 250mg) as Maintenance Therapy in Locally Advanced or Metastatic (Stage IIIB/IV) Non Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT00770588. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study of Pemetrexed and Gefitinib Versus Gefitinib in Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT01469000. IPD Sharing: YES. Countries: 4. Publications: 1.
Tepotinib With Gefitinib in Participants With Locally Advanced or Metastatic NSCLC (INSIGHT)
ClinicalTrials.gov study NCT01982955. IPD Sharing: Not stated. Countries: 7. Publications: 1.
Phase II Study of Skin Toxicity Dosing of IRESSA (Gefitinib) in Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT00519077. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of ASP8273 vs. Erlotinib or Gefitinib in First-line Treatment of Patients With Stage IIIB/IV Non-small Cell Lung Cancer Tumors With EGFR Activating Mutations
ClinicalTrials.gov study NCT02588261. IPD Sharing: YES. Countries: 23. Publications: 1.
AZD9291 Versus Gefitinib or Erlotinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT02296125. IPD Sharing: YES. Countries: 30. Publications: 13.
Phase II Trial to Correlate Radiographic Response Induced By Gefitinib With Mutations in the Protein-Tyrosine Kinase Domain of the EGF Receptor Gene
ClinicalTrials.gov study NCT00588445. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Topotecan and Gefitinib (Iressa) for Ovarian, Peritoneal, or Fallopian Tube Cancer
ClinicalTrials.gov study NCT00317772. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study With Gefitinib in Combination With Olaparib (AZD2281) Versus Gefitinib Alone
ClinicalTrials.gov study NCT01513174. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Gefitinib in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer That Did Not Respond to Iodine Therapy
ClinicalTrials.gov study NCT00095836. IPD Sharing: Not stated. Countries: 1. Publications: 1.
BIBW 2992 and BSC Versus Placebo and BSC in Non-small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib (LUX-LUNG 1)
ClinicalTrials.gov study NCT00656136. IPD Sharing: Not stated. Countries: 15. Publications: 1.
Gefitinib and PEG-Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney Cancer
ClinicalTrials.gov study NCT00467077. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Gefitinib and Everolimus in Treating Patients With Stage IIIB or Stage IV or Recurrent Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00096486. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Dasatinib in Treating Patients With Advanced Lung Cancer That Is No Longer Responding to Erlotinib or Gefitinib
ClinicalTrials.gov study NCT00570401. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.